The Zonulin-transgenic mouse displays behavioral alterations ameliorated via depletion of the gut microbiota

References

• Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006;55(10):1–25. doi:10.1136/gut.2005.085373.
   PubMed Web of Science ®Google Scholar
• Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol. 2005;2(9):416–422. doi:10.1038/ncpgasthep0259.
   PubMedGoogle Scholar
• Wapenaar MC, Monsuur AJ, Van Bodegraven AA, Weersma RK, Bevova MR, Linskens RK, Howdle P, Holmes G, Mulder CJ, Dijkstra G, et al. Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut. 2008;57(4):463–467. doi:10.1136/gut.2007.133132.
   PubMed Web of Science ®Google Scholar
• Mowat AM, Millington OR, Chirdo FG. Anatomical and cellular basis of immunity and tolerance in the intestine. J Pediatr Gastroenterol Nutr. 2004;39(Suppl 3):S723–4. doi:10.1097/00005176-200406003-00003.
   PubMed Web of Science ®Google Scholar
• Rescigno M. Intestinal microbiota and its effects on the immune system. Cell Microbiol. 2014;16(7):1004–1013. doi:10.1111/cmi.12301.
   PubMed Web of Science ®Google Scholar
• Rescigno M, Lopatin U, Chieppa M. Interactions among dendritic cells, macrophages, and epithelial cells in the gut: implications for immune tolerance. Curr Opin Immunol. 2008;20(6):669–675. doi:10.1016/j.coi.2008.09.007.
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Homeostatic impact of indigenous microbiota and secretory immunity. Benef Microbes. 2010;1(3):211–227. doi:10.3920/BM2010.0009.
   PubMed Web of Science ®Google Scholar
• Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9(11):799–809. doi:10.1038/nri2653.
   PubMed Web of Science ®Google Scholar
• Fang X. Potential role of gut microbiota and tissue barriers in Parkinson’s disease and amyotrophic lateral sclerosis. Int J Neurosci. 2016;126(9):771–776. doi:10.3109/00207454.2015.1096271.
   PubMed Web of Science ®Google Scholar
• Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2015;14(6):625–639. doi:10.1016/S1474-4422(15)00007-1.
   PubMed Web of Science ®Google Scholar
• Rowin J, Xia Y, Jung B, Sun J. Gut inflammation and dysbiosis in human motor neuron disease. Physiol Rep. 2017;5(18):e13443. doi:10.14814/phy2.13443.
   PubMed Web of Science ®Google Scholar
• Toepfer M, Folwaczny, C, Klauser, A, Riepl, RL, Müller-Felber, W, and Pongratz, D, Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999;1(1):15–19. doi:10.1080/146608299300079484.
   PubMed Web of Science ®Google Scholar
• Zhang R, Miller RG, Gascon R, Champion S, Katz J, Lancero M, Narvaez A, Honrada R, Ruvalcaba D, McGrath MS, et al. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol. 2009;206(1–2):121–124. doi:10.1016/j.jneuroim.2008.09.017.
   PubMed Web of Science ®Google Scholar
• Hill JM, Bhattacharjee S, Pogue AI, Lukiw WJ. The Gastrointestinal Tract Microbiome and Potential Link to Alzheimer’s Alzheimer’s Disease. Front Neurol. 2014;5:43. doi:10.3389/fneur.2014.00043.
   PubMedGoogle Scholar
• Kirby TO, and Ochoa-Reparaz J. The Gut Microbiome in Multiple Sclerosis: a Potential Therapeutic Avenue. Med Sci (Basel). 2018;6(3 69 doi:10.3390/medsci6030069).
   Google Scholar
• Buscarinu MC, et al. The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology. Front Immunol. 2019;10:1916. doi:10.3389/fimmu.2019.01916.
   PubMedGoogle Scholar
• Rose DR, Yang H, Serena G, Sturgeon C, Ma B, Careaga M, Hughes HK, Angkustsiri K, Rose M, Hertz-Picciotto I, et al. Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms. Brain Behav Immun. 2018;70:354–368. doi:10.1016/j.bbi.2018.03.025.
   PubMed Web of Science ®Google Scholar
• Morais LH, Schreiber HL, Mazmanian SK. The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol. 2020.
   PubMed Web of Science ®Google Scholar
• Motil KJ, Caeg E, Barrish JO, Geerts S, Lane JB, Percy AK, Annese F, McNair L, Skinner SA, Lee H-S, et al. Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome. J Pediatr Gastroenterol Nutr. 2012;55(3):292–298. doi:10.1097/MPG.0b013e31824b6159.
   PubMed Web of Science ®Google Scholar
• Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, Hayek J, Jousson O, Leoncini S, Renzi D, Calabrò A, et al. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome. 2017;5(1):24. doi:10.1186/s40168-017-0242-1.
   PubMed Web of Science ®Google Scholar
• Kang V, Wagner GC, Ming X. Gastrointestinal dysfunction in children with autism spectrum disorders. Autism Res. 2014;7(4):501–506. doi:10.1002/aur.1386.
   PubMed Web of Science ®Google Scholar
• Duel BP, et al. A survey of voiding dysfunction in children with attention deficit-hyperactivity disorder. J Urol. 2003;170(4 Pt 2):1521–1523. discussion 1523-4. doi:10.1097/01.ju.0000091219.46560.7b.
   PubMed Web of Science ®Google Scholar
• Jameson ND, et al. Medical Comorbidity of Attention-Deficit/Hyperactivity Disorder in US Adolescents. J Child Neurol. 2016;31(11):522–529. doi:10.1177/0883073816653782.
   Web of Science ®Google Scholar
• Ming X, et al. A Gut Feeling: a Hypothesis of the Role of the Microbiome in Attention-Deficit/Hyperactivity Disorders. Child Neurol Open. 2018;5:2329048X18786799. doi:10.1177/2329048X18786799.
   PubMedGoogle Scholar
• Severance EG, Dickerson F, Yolken RH. Complex Gastrointestinal and Endocrine Sources of Inflammation in Schizophrenia. Front Psychiatry. 2020;11:549. doi:10.3389/fpsyt.2020.00549.
   PubMed Web of Science ®Google Scholar
• Severance EG, Prandovszky E, Castiglione J, Yolken RH. Gastroenterology issues in schizophrenia: why the gut matters. Curr Psychiatry Rep. 2015;17(5):27. doi:10.1007/s11920-015-0574-0.
   PubMed Web of Science ®Google Scholar
• Molloy CA, Manning-Courtney P. Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism. 2003;7(2):165–171. doi:10.1177/1362361303007002004.
   PubMed Web of Science ®Google Scholar
• Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000;355(9214):1518–1519. doi:10.1016/S0140-6736(00)02169-3.
   PubMed Web of Science ®Google Scholar
• Fasano A. Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin. Ann N Y Acad Sci. 2000;915(1):214–222. doi:10.1111/j.1749-6632.2000.tb05244.x.
   PubMedGoogle Scholar
• Wang W, Uzzau S, Goldblum SE, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci. 2000;113(Pt 24):4435–4440. doi:10.1242/jcs.113.24.4435.
   PubMed Web of Science ®Google Scholar
• Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A. 2009;106(39):16799–16804. doi:10.1073/pnas.0906773106.
   PubMed Web of Science ®Google Scholar
• Sapone A, De Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F, Lampis R, Kryszak D, Carteni M, Generoso M, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006;55(5):1443–1449. doi:10.2337/db05-1593.
   PubMed Web of Science ®Google Scholar
• Esnafoglu E, Cırrık S, Ayyıldız SN, Erdil A, Ertürk EY, Daglı A, Noyan T. Increased Serum Zonulin Levels as an Intestinal Permeability Marker in Autistic Subjects. J Pediatr. 2017;188:240–244. doi:10.1016/j.jpeds.2017.04.004.
   PubMed Web of Science ®Google Scholar
• Ozyurt G, Öztürk Y, Appak YÇ, Arslan FD, Baran M, Karakoyun İ, Tufan AE, Pekcanlar AA. Increased zonulin is associated with hyperactivity and social dysfunctions in children with attention deficit hyperactivity disorder. Compr Psychiatry. 2018;87:138–142. doi:10.1016/j.comppsych.2018.10.006.
   PubMed Web of Science ®Google Scholar
• D’Eufemia P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, Zaccagnini M, Cardi E, Giardini O. Abnormal intestinal permeability in children with autism. Acta Paediatr. 1996;85(9):1076–1079. doi:10.1111/j.1651-2227.1996.tb14220.x.
   PubMed Web of Science ®Google Scholar
• De Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, Francavilla R, Riegler G, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr. 2010;51(4):418–424. doi:10.1097/MPG.0b013e3181dcc4a5.
   PubMed Web of Science ®Google Scholar
• Lau NM, Green PHR, Taylor AK, Hellberg D, Ajamian M, Tan CZ, Kosofsky BE, Higgins JJ, Rajadhyaksha AM, Alaedini A, et al. Markers of Celiac Disease and Gluten Sensitivity in Children with Autism. PLoS One. 2013;8(6):e66155. doi:10.1371/journal.pone.0066155.
   PubMed Web of Science ®Google Scholar
• Maes M, Sirivichayakul S, Kanchanatawan B, Vodjani A. Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia. Mol Neurobiol. 2019;56(10):7056–7073. doi:10.1007/s12035-019-1578-2.
   PubMed Web of Science ®Google Scholar
• El Asmar R, Panigrahi P, Bamford P, Berti I, Not T, Coppa GV, Catassi C, Fasano A. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology. 2002;123(5):1607–1615. doi:10.1053/gast.2002.36578.
   PubMed Web of Science ®Google Scholar
• Alaish SM, Smith AD, Timmons J, Greenspon J, Eyvazzadeh D, Murphy E, Shea-Donahue T, Cirimotich S, Mongodin E, Zhao A, et al. Gut microbiota, tight junction protein expression, intestinal resistance, bacterial translocation and mortality following cholestasis depend on the genetic background of the host. Gut Microbes. 2013;4(4):292–305. doi:10.4161/gmic.24706.
   PubMed Web of Science ®Google Scholar
• Drago S, et al. Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol. 2006;41(4):408–419. doi:10.1080/00365520500235334.
   PubMed Web of Science ®Google Scholar
• Parracho HM, et al. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol. 2005;54(Pt 10):987–991.
   PubMed Web of Science ®Google Scholar
• Finegold SM. Desulfovibrio species are potentially important in regressive autism. Med Hypotheses. 2011;77(2): 16799–4. doi:10.1016/j.mehy.2011.04.032.
   PubMed Web of Science ®Google Scholar
• Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010;16(4):444–453. doi:10.1016/j.anaerobe.2010.06.008.
   PubMed Web of Science ®Google Scholar
• Adams JB, et al. Gastrointestinal flora and gastrointestinal status in children with autism–comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011;11(1):22. doi:10.1186/1471-230X-11-22.
   PubMedGoogle Scholar
• Wang L, et al. Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl Environ Microbiol. 2011;77(18):6718–6721. doi:10.1128/AEM.05212-11.
   PubMed Web of Science ®Google Scholar
• Williams BL, Hornig M, Buie T, Bauman ML, Cho Paik M, Wick I, Bennett A, Jabado O, Hirschberg DL, Lipkin WI, et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One. 2011;6(9):e24585. doi:10.1371/journal.pone.0024585.
   PubMed Web of Science ®Google Scholar
• Zou R, et al. Dysbiosis of Gut Fungal Microbiota in Children with Autism Spectrum Disorders. J Autism Dev Disord. 2020.
   PubMedGoogle Scholar
• Zou R, Xu F, Wang Y, Duan M, Guo M, Zhang Q, Zhao H, Zheng H. Changes in the Gut Microbiota of Children with Autism Spectrum Disorder. Autism Res. 2020;13(9):1614–1625. doi:10.1002/aur.2358.
   PubMed Web of Science ®Google Scholar
• Jakobsson HE, Rodríguez‐Piñeiro AM, Schütte A, Ermund A, Boysen P, Bemark M, Sommer F, Bäckhed F, Hansson GC, Johansson ME, et al. The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep. 2015;16(2):164–177. doi:10.15252/embr.201439263.
   PubMed Web of Science ®Google Scholar
• Alvarez CS, Badia J, Bosch M, Giménez R, Baldomà L. Outer Membrane Vesicles and Soluble Factors Released by Probiotic Escherichia coli Nissle 1917 and Commensal ECOR63 Enhance Barrier Function by Regulating Expression of Tight Junction Proteins in Intestinal Epithelial Cells. Front Microbiol. 2016;7:1981. doi:10.3389/fmicb.2016.01981.
   PubMed Web of Science ®Google Scholar
• Bischoff SC, et al. Intestinal permeability–a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189.
   PubMed Web of Science ®Google Scholar
• Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110(22):9066–9071. doi:10.1073/pnas.1219451110.
   PubMed Web of Science ®Google Scholar
• Deng H, Yang S, Zhang Y, Qian K, Zhang Z, Liu Y, Wang Y, Bai Y, Fan H, Zhao X, et al. Bacteroides fragilis Prevents Clostridium difficile Infection in a Mouse Model by Restoring Gut Barrier and Microbiome Regulation. Front Microbiol. 2018;9:2976. doi:10.3389/fmicb.2018.02976.
   PubMed Web of Science ®Google Scholar
• Chiaro TR, Soto R, Zac Stephens W, Kubinak JL, Petersen C, Gogokhia L, Bell R, Delgado JC, Cox J, Voth W, et al. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Sci Transl Med. 2017;9(380). doi:10.1126/scitranslmed.aaf9044.
   PubMed Web of Science ®Google Scholar
• Martin R, Laval L, Chain F, Miquel S, Natividad J, Cherbuy C, Sokol H, Verdu EF, Van Hylckama Vlieg J, Bermudez-Humaran LG, et al. Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice. Front Microbiol. 2016;7:608. doi:10.3389/fmicb.2016.00608.
   PubMed Web of Science ®Google Scholar
• Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer RJM, Wells JM. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol. 2010;298(6):G851–9. doi:10.1152/ajpgi.00327.2009.
   PubMed Web of Science ®Google Scholar
• Alhasson F, et al. Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation. PLoS One. 2017;12(3):e0172914. doi:10.1371/journal.pone.0172914.
   PubMed Web of Science ®Google Scholar
• Wang S, Li Q, Zang Y, Zhao Y, Liu N, Wang Y, Xu X, Liu L, Mei Q. Apple Polysaccharide inhibits microbial dysbiosis and chronic inflammation and modulates gut permeability in HFD-fed rats. Int J Biol Macromol. 2017;99:282–292. doi:10.1016/j.ijbiomac.2017.02.074.
   PubMed Web of Science ®Google Scholar
• Thevaranjan N, Puchta A, Schulz C, Naidoo A, Szamosi JC, Verschoor CP, Loukov D, Schenck LP, Jury J, Foley KP, et al. Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction. Cell Host Microbe. 2018;23(4):570. doi:10.1016/j.chom.2018.03.006.
   PubMed Web of Science ®Google Scholar
• Martinez-Oca P, et al. Gut DYSBIOSIS and altered barrier function precedes the appearance of metabolic syndrome in a rat model of nutrient-induced catch-up growth. J Nutr Biochem. 2020;81:108383. doi:10.1016/j.jnutbio.2020.108383.
   PubMed Web of Science ®Google Scholar
• Brandl K, Schnabl B. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease? Expert Rev Gastroenterol Hepatol. 2015;9(8):1069–1076. doi:10.1586/17474124.2015.1057122.
   PubMed Web of Science ®Google Scholar
• Gasmi A, et al. Relationship between gut microbiota, gut hyperpermeability, and obesity. Curr Med Chem. 2020.
   Web of Science ®Google Scholar
• Marizzoni M, Provasi S, Cattaneo A, Frisoni GB. Microbiota and neurodegenerative diseases. Curr Opin Neurol. 2017;30(6):630–638. doi:10.1097/WCO.0000000000000496.
   PubMed Web of Science ®Google Scholar
• Sochocka M, Donskow-Łysoniewska K, Diniz BS, Kurpas D, Brzozowska E, Leszek J. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease-a Critical Review. Mol Neurobiol. 2019;56(3):1841–1851. doi:10.1007/s12035-018-1188-4.
   PubMed Web of Science ®Google Scholar
• Potgieter M, Bester J, Kell DB, Pretorius E. The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev. 2015;39(4):567–591. doi:10.1093/femsre/fuv013.
   PubMed Web of Science ®Google Scholar
• Konig J, Wells J, Cani PD, García-Ródenas CL, MacDonald T, Mercenier A, Whyte J, Troost F, Brummer R-J. Human Intestinal Barrier Function in Health and Disease. Clin Transl Gastroenterol. 2016;7(10):e196. doi:10.1038/ctg.2016.54.
   PubMed Web of Science ®Google Scholar
• Wardill HR, Mander KA, Van Sebille YZA, Gibson RJ, Logan RM, Bowen JM, Sonis ST. Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction. Int J Cancer. 2016;139(12):2635–2645. doi:10.1002/ijc.30252.
   PubMed Web of Science ®Google Scholar
• Elahy M, Jackaman C, Mamo JC, Lam V, Dhaliwal SS, Giles C, Nelson D, Takechi R. Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment. Immun Ageing. 2015;12(1):2. doi:10.1186/s12979-015-0029-9.
   PubMedGoogle Scholar
• Wang J, Song Y, Chen Z, Leng SX. Connection between Systemic Inflammation and Neuroinflammation Underlies Neuroprotective Mechanism of Several Phytochemicals in Neurodegenerative Diseases. Oxid Med Cell Longev. 2018;2018:1972714. doi:10.1155/2018/1972714.
   PubMed Web of Science ®Google Scholar
• Wu S, Yi J, Zhang Y-G, Zhou J, Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol Rep. 2015;3(4):e12356. doi:10.14814/phy2.12356.
   PubMed Web of Science ®Google Scholar
• Buscarinu MC, et al. Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study. Mult Scler. 2017;23(3):442–446.
   PubMed Web of Science ®Google Scholar
• Buscarinu MC, Romano S, Mechelli R, Pizzolato Umeton R, Ferraldeschi M, Fornasiero A, Reniè R, Cerasoli B, Morena E, Romano C, et al. Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis. Neurotherapeutics. 2018;15(1):68–74. doi:10.1007/s13311-017-0582-3.
   PubMed Web of Science ®Google Scholar
• Moor AC, De Vries HE, De Boer AG, Breimer DD. The blood-brain barrier and multiple sclerosis. Biochem Pharmacol. 1994;47(10):1717–1724. doi:10.1016/0006-2952(94)90297-6.
   PubMed Web of Science ®Google Scholar
• Soon D, Tozer DJ, Altmann DR, Tofts PS, Miller DH. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Mult Scler. 2007;13(7):884–894. doi:10.1177/1352458507076970.
   PubMed Web of Science ®Google Scholar
• Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler. 2003;9:540–549.
   PubMed Web of Science ®Google Scholar
• Gray MT, Woulfe JM. Striatal blood-brain barrier permeability in Parkinson’s disease. J Cereb Blood Flow Metab. 2015;35:747–750.
   PubMed Web of Science ®Google Scholar
• Wada H. Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio. Intern Med. 1998;37(6):509–513. doi:10.2169/internalmedicine.37.509.
   PubMed Web of Science ®Google Scholar
• Bell RD, Zlokovic BV. Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease. Acta Neuropathol. 2009;118(1):103–113. doi:10.1007/s00401-009-0522-3.
   PubMed Web of Science ®Google Scholar
• Weissberg I, et al. Blood-brain barrier dysfunction in epileptogenesis of the temporal lobe. Epilepsy Res Treat. 2011;2011:143908.
   PubMedGoogle Scholar
• Heinemann U, Kaufer D, Friedman A. Blood-brain barrier dysfunction, TGFbeta signaling, and astrocyte dysfunction in epilepsy. Glia. 2012;60(8):1251–1257. doi:10.1002/glia.22311.
   PubMed Web of Science ®Google Scholar
• Cassani E, Barichella M, Cancello R, Cavanna F, Iorio L, Cereda E, Bolliri C, Zampella Maria P, Bianchi F, Cestaro B, et al. Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(4):389–393. doi:10.1016/j.parkreldis.2015.02.004.
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM. Colonic bacterial composition in Parkinson’s disease. Mov Disord. 2015;30(10):1351–1360. doi:10.1002/mds.26307.
   PubMed Web of Science ®Google Scholar
• Scheperjans F, Aho V, Pereira PAB, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola‐Rautio J, Pohja M, et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord. 2015;30(3):350–358. doi:10.1002/mds.26069.
   PubMed Web of Science ®Google Scholar
• Unger MM, et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls. Parkinsonism Relat Disord. 2016;32:66–72. doi:10.1016/j.parkreldis.2016.08.019.
   PubMed Web of Science ®Google Scholar
• Zhuang Z-Q, et al. Gut Microbiota is Altered in Patients with Alzheimer’s Disease. J Alzheimers Dis. 2018;63(4):1337–1346. doi:10.3233/JAD-180176.
   PubMed Web of Science ®Google Scholar
• Miyake S, et al. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One. 2015;10(9):e0137429. doi:10.1371/journal.pone.0137429.
   PubMed Web of Science ®Google Scholar
• Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Paz Soldan MM, Luckey DH, Marietta EV, Jeraldo PR, Chen X, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep. 2016;6(1):28484. doi:10.1038/srep28484.
   PubMed Web of Science ®Google Scholar
• Jangi S, Gandhi R, Cox LM, Li N, Von Glehn F, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016;7(1):12015. doi:10.1038/ncomms12015.
   PubMed Web of Science ®Google Scholar
• Vogt NM, Kerby RL, Dill-mcfarland KA, Harding SJ, Merluzzi AP, Johnson SC, Carlsson CM, Asthana S, Zetterberg H, Blennow K, et al. Gut microbiome alterations in Alzheimer’s disease. Sci Rep. 2017;7(1):13537. doi:10.1038/s41598-017-13601-y.
   PubMed Web of Science ®Google Scholar
• Cattaneo A, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60–68. doi:10.1016/j.neurobiolaging.2016.08.019.
   PubMed Web of Science ®Google Scholar
• Kang DW, Park JG, Ilhan ZE, Wallstrom G, LaBaer J, Adams JB, Krajmalnik-Brown R. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One. 2013;8(7):e68322. doi:10.1371/journal.pone.0068322.
   PubMed Web of Science ®Google Scholar
• Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA. Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Mol Autism. 2013;4(1):42. doi:10.1186/2040-2392-4-42.
   PubMed Web of Science ®Google Scholar
• Tomova A, Husarova V, Lakatosova S, Bakos J, Vlkova B, Babinska K, Ostatnikova D. Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav. 2015;138:179–187. doi:10.1016/j.physbeh.2014.10.033.
   PubMed Web of Science ®Google Scholar
• Luna RA, Oezguen N, Balderas M, Venkatachalam A, Runge JK, Versalovic J, Veenstra-vanderweele J, Anderson GM, Savidge T, Williams KC, et al. Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder. Cell Mol Gastroenterol Hepatol. 2017;3(2):218–230. doi:10.1016/j.jcmgh.2016.11.008.
   PubMed Web of Science ®Google Scholar
• Kang DW, Ilhan ZE, Isern NG, Hoyt DW, Howsmon DP, Shaffer M, Lozupone CA, Hahn J, Adams JB, Krajmalnik-Brown R, et al. Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders. Anaerobe. 2018;49:121–131. doi:10.1016/j.anaerobe.2017.12.007.
   PubMed Web of Science ®Google Scholar
• Lv F, Chen S, Wang L, Jiang R, Tian H, Li J, Yao Y, Zhuo C. The role of microbiota in the pathogenesis of schizophrenia and major depressive disorder and the possibility of targeting microbiota as a treatment option. Oncotarget. 2017;8(59):100899–100907. doi:10.18632/oncotarget.21284.
   PubMedGoogle Scholar
• Severance EG, Gressitt KL, Stallings CR, Origoni AE, Khushalani S, Leweke FM, Dickerson FB, Yolken RH. Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr Res. 2013;148(1–3):130–137. doi:10.1016/j.schres.2013.05.018.
   PubMed Web of Science ®Google Scholar
• Melkersson K, Bensing S. Signs of impaired blood-brain barrier function and lower IgG synthesis within the central nervous system in patients with schizophrenia or related psychosis, compared to that in controls. Neuro Endocrinol Lett. 2018;39:33–42.
   PubMed Web of Science ®Google Scholar
• Fiorentino M, Sapone A, Senger S, Camhi SS, Kadzielski SM, Buie TM, Kelly DL, Cascella N, Fasano A. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism. 2016;7(1):49. doi:10.1186/s13229-016-0110-z.
   PubMedGoogle Scholar
• Rahman MT, Ghosh C, Hossain M, Linfield D, Rezaee F, Janigro D, Marchi N, Van Boxel-dezaire AHH. IFN-gamma, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: relevance for neuro-inflammatory diseases. Biochem Biophys Res Commun. 2018;507(1–4):274–279. doi:10.1016/j.bbrc.2018.11.021.
   PubMed Web of Science ®Google Scholar
• Diaz-Coranguez M, Segovia J, López-Ornelas A, Puerta-Guardo H, Ludert J, Chávez B, Meraz-Cruz N, González-Mariscal L. Transmigration of neural stem cells across the blood brain barrier induced by glioma cells. PLoS One. 2013;8(4):e60655. doi:10.1371/journal.pone.0060655.
   PubMed Web of Science ®Google Scholar
• Skardelly M, Armbruster FP, Meixensberger J, Hilbig H. Expression of Zonulin, c-kit, and Glial Fibrillary Acidic Protein in Human Gliomas. Transl Oncol. 2009;2(3):117–120. doi:10.1593/tlo.09115.
   PubMed Web of Science ®Google Scholar
• Singer HS, Morris CM, Williams PN, Yoon DY, Hong JJ, Zimmerman AW. Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol. 2006;178(1–2):149–155. doi:10.1016/j.jneuroim.2006.05.025.
   PubMed Web of Science ®Google Scholar
• Zimmerman AW, Connors SL, Matteson KJ, Lee L-C, Singer HS, Castaneda JA, Pearce DA. Maternal antibrain antibodies in autism. Brain Behav Immun. 2007;21(3):351–357. doi:10.1016/j.bbi.2006.08.005.
   PubMed Web of Science ®Google Scholar
• Braunschweig D, Van De Water J. Maternal autoantibodies in autism. Arch Neurol. 2012;69(6):693–699. doi:10.1001/archneurol.2011.2506.
   PubMedGoogle Scholar
• Eshraghi RS, Davies C, Iyengar R, Perez L, Mittal R, Eshraghi AA. Gut-Induced Inflammation during Development May Compromise the Blood-Brain Barrier and Predispose to Autism Spectrum Disorder. J Clin Med. 2020;10(1):27. doi:10.3390/jcm10010027.
   Web of Science ®Google Scholar
• Levy AP, Levy JE, Kalet-Litman S, Miller-Lotan R, Levy NS, Asaf R, Guetta J, Yang C, Purushothaman KR, Fuster V, et al. Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 2007;27(1):134–140. doi:10.1161/01.ATV.0000251020.24399.a2.
   PubMed Web of Science ®Google Scholar
• Sturgeon C, Lan J, Fasano A. Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model. Ann N Y Acad Sci. 2017;1397(1):130–142. doi:10.1111/nyas.13343.
   PubMed Web of Science ®Google Scholar
• Miranda-Ribera A, Ennamorati M, Serena G, Cetinbas M, Lan J, Sadreyev RI, Jain N, Fasano A, Fiorentino M. Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles. Front Immunol. 2019;10:2233. doi:10.3389/fimmu.2019.02233.
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118(2):229–241. doi:10.1016/j.cell.2004.07.002.
   PubMed Web of Science ®Google Scholar
• Thomas A, Burant A, Bui N, Graham D, Yuva-Paylor LA, Paylor R. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacol (Berl). 2009;204(2):361–373. doi:10.1007/s00213-009-1466-y.
   PubMed Web of Science ®Google Scholar
• Chang YC, Cole TB, Costa LG. Behavioral Phenotyping for Autism Spectrum Disorders in Mice. Curr Protoc Toxicol. 2017;72(1):11 22 1–11 22 21. doi:10.1002/cptx.19.
   Google Scholar
• Shinomiya K, Fujii Y, Sugimoto Y, Azuma N, Tokunaga S, Kitazumi K, Kamei C. Effect of paroxetine on marble-burying behavior in mice. Methods Find Exp Clin Pharmacol. 2005;27(10):685–687. doi:10.1358/mf.2005.27.10.948883.
   PubMedGoogle Scholar
• Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463(1–3):3–33. doi:10.1016/S0014-2999(03)01272-X.
   PubMed Web of Science ®Google Scholar
• Kraeuter AK, Guest PC, Sarnyai Z. The Open Field Test for Measuring Locomotor Activity and Anxiety-Like Behavior. Methods Mol Biol. 2019;1916:99–103.
   PubMedGoogle Scholar
• Gentsch C, Lichtsteiner M, Feer H. Open field and elevated plus-maze: a behavioural comparison between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats and the effects of chlordiazepoxide. Behav Brain Res. 1987;25(2):101–107. doi:10.1016/0166-4328(87)90003-9.
   PubMed Web of Science ®Google Scholar
• Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT. Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety. Psychopharmacol (Berl). 1994;116(1):56–64. doi:10.1007/BF02244871.
   PubMedGoogle Scholar
• Brown RL, Sequeira RP, Clarke TB. The microbiota protects against respiratory infection via GM-CSF signaling. Nat Commun. 2017;8(1):1512. doi:10.1038/s41467-017-01803-x.
   PubMed Web of Science ®Google Scholar
• Baldridge MT, Nice TJ, McCune BT, Yokoyama CC, Kambal A, Wheadon M, Diamond MS, Ivanova Y, Artyomov M, Virgin HW, et al. Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection. Science. 2015;347(6219):266–269. doi:10.1126/science.1258025.
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N, Knight R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4516–4522. doi:10.1073/pnas.1000080107.
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–336. doi:10.1038/nmeth.f.303.
   PubMed Web of Science ®Google Scholar
• Amir A, McDonald D, Navas-Molina JA, Kopylova E, Morton JT, Zech Xu Z, Kightley EP, Thompson LR, Hyde ER, Gonzalez A, et al. Deblur Rapidly Resolves Single-Nucleotide Community Sequence Patterns. mSystems. 2017;2(2). doi:10.1128/mSystems.00191-16.
   Web of Science ®Google Scholar
• Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30(4):772–780. doi:10.1093/molbev/mst010.
   PubMed Web of Science ®Google Scholar
• Price MN, Dehal PS, Arkin AP, Poon AFY. FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS One. 2010;5(3):e9490. doi:10.1371/journal.pone.0009490.
   PubMed Web of Science ®Google Scholar
• Mandal S, et al. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb Ecol Health Dis. 2015;26:27663.
   PubMedGoogle Scholar
• Camara-Lemarroy CR, et al. Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity. Mult Scler. 2019;1352458519863133.
   Google Scholar
• Kilic F, Işık Ü, Demirdaş A, Doğuç DK, Bozkurt M. Serum zonulin and claudin-5 levels in patients with bipolar disorder. J Affect Disord. 2020;266:37–42. doi:10.1016/j.jad.2020.01.117.
   PubMed Web of Science ®Google Scholar
• Usta A, et al. Serum zonulin and claudin-5 levels in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2020.
   PubMed Web of Science ®Google Scholar
• Barber GS, Sturgeon C, Fasano A, Cascella NG, Eaton WW, McMahon RP, Kelly DL. Elevated zonulin, a measure of tight-junction permeability, may be implicated in schizophrenia. Schizophr Res. 2019;211:111–112. doi:10.1016/j.schres.2019.07.006.
   PubMed Web of Science ®Google Scholar
• Ciccia F, Guggino G, Rizzo A, Alessandro R, Luchetti MM, Milling S, Saieva L, Cypers H, Stampone T, Di Benedetto P, et al. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann Rheum Dis. 2017;76(6):1123–1132. doi:10.1136/annrheumdis-2016-210000.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jin S, Sonobe Y, Cheng Y, Horiuchi H, Parajuli B, Kawanokuchi J, Mizuno T, Takeuchi H, Suzumura A, et al. Interleukin-1beta induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes. PLoS One. 2014;9(10):e110024. doi:10.1371/journal.pone.0110024.
   PubMed Web of Science ®Google Scholar
• Ching S, He L, Lai W, Quan N. IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system. Brain Behav Immun. 2005;19(2):127–137. doi:10.1016/j.bbi.2004.06.001.
   PubMed Web of Science ®Google Scholar
• Pare A, Mailhot B, Lévesque SA, Juzwik C, Ignatius Arokia Doss PM, Lécuyer M-A, Prat A, Rangachari M, Fournier A, Lacroix S, et al. IL-1β enables CNS access to CCR2 hi monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells. Proc Natl Acad Sci U S A. 2018;115(6):E1194–E1203. E1194-E1203. doi:10.1073/pnas.1714948115.
   PubMed Web of Science ®Google Scholar
• Cryan JF, Kaupmann K. Don’t worry ‘B’ happy!: a role for GABA(B) receptors in anxiety and depression. Trends Pharmacol Sci. 2005;26(1):36–43. doi:10.1016/j.tips.2004.11.004.
   PubMed Web of Science ®Google Scholar
• Schousboe A, Waagepetersen HS. GABA: homeostatic and pharmacological aspects. Prog Brain Res. 2007;160:9–19.
   PubMed Web of Science ®Google Scholar
• Mohler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology. 2012;62(1):42–53. doi:10.1016/j.neuropharm.2011.08.040.
   PubMed Web of Science ®Google Scholar
• Kalueff A, Nutt DJ. Role of GABA in memory and anxiety. Depress Anxiety. 1996;4(3):100–110. doi:10.1002/(SICI)1520-6394(1996)4:3<100::AID-DA2>3.0.CO;2-K.
   PubMedGoogle Scholar
• Song DK, et al. Central GABAA and GABAB receptor modulation of basal and stress-induced plasma interleukin-6 levels in mice. J Pharmacol Exp Ther. 1998;287(1):144–149.
   PubMed Web of Science ®Google Scholar
• Ito Y, Banno R, Shibata M, Adachi K, Hagimoto S, Hagiwara D, Ozawa Y, Goto M, Suga H, Sugimura Y, et al. GABA type B receptor signaling in proopiomelanocortin neurons protects against obesity, insulin resistance, and hypothalamic inflammation in male mice on a high-fat diet. J Neurosci. 2013;33(43):17166–17173. doi:10.1523/JNEUROSCI.0897-13.2013.
   PubMed Web of Science ®Google Scholar
• Kuhn SA, Van Landeghem FKH, Zacharias R, Färber K, Rappert A, Pavlovic S, Hoffmann A, Nolte C, Kettenmann H. Microglia express GABA(B) receptors to modulate interleukin release. Mol Cell Neurosci. 2004;25(2):312–322. doi:10.1016/j.mcn.2003.10.023.
   PubMed Web of Science ®Google Scholar
• Guyon A, Kussrow A, Olmsted IR, Sandoz G, Bornhop DJ, Nahon J-L. Baclofen and other GABAB receptor agents are allosteric modulators of the CXCL12 chemokine receptor CXCR4. J Neurosci. 2013;33(28):11643–11654. doi:10.1523/JNEUROSCI.6070-11.2013.
   PubMed Web of Science ®Google Scholar
• Lee M, Schwab C, McGeer PL. Astrocytes are GABAergic cells that modulate microglial activity. Glia. 2011;59(1):152–165. doi:10.1002/glia.21087.
   PubMed Web of Science ®Google Scholar
• Crowley T, Fitzpatrick J-M, Kuijper T, Cryan JF, O’Toole O, O’Leary OF, Downer EJ. Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis. Front Cell Neurosci. 2015;9:284. doi:10.3389/fncel.2015.00284.
   PubMed Web of Science ®Google Scholar
• Liu GX, Cai G-Q, Cai Y-Q, Sheng Z-J, Jiang J, Mei Z, Wang Z-G, Guo L, Fei J. Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Neuropsychopharmacology. 2007;32(7):1531–1539. doi:10.1038/sj.npp.1301281.
   PubMed Web of Science ®Google Scholar
• Kjeldsen TH, Hansen EW, Christensen JD, Moesby L. Baclofen influences lipopolysaccharide-mediated interleukin-6 release from murine pituicytes. Eur J Pharmacol. 2002;451(2):209–215. doi:10.1016/S0014-2999(02)02222-7.
   PubMed Web of Science ®Google Scholar
• Kim KA, Gu W, Lee I-A, Joh E-H, Kim D-H. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One. 2012;7(10):e47713. doi:10.1371/journal.pone.0047713.
   PubMed Web of Science ®Google Scholar
• Leiva-Gea I, Sánchez-Alcoholado L, Martín-Tejedor B, Castellano-Castillo D, Moreno-Indias I, Urda-Cardona A, Tinahones FJ, Fernández-García JC, Queipo-Ortuño MI. Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: a Case-Control Study. Diabetes Care. 2018;41(11):2385–2395. doi:10.2337/dc18-0253.
   PubMed Web of Science ®Google Scholar
• Geurts L, Lazarevic V, Derrien M, Everard A, Van Roye M, Knauf C, Valet P, Girard M, Muccioli GG, François P, et al. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol. 2011;2:149. doi:10.3389/fmicb.2011.00149.
   PubMed Web of Science ®Google Scholar
• Alkadhi S, Kunde D, Cheluvappa R, Randall-Demllo S, Eri R. The murine appendiceal microbiome is altered in spontaneous colitis and its pathological progression. Gut Pathog. 2014;6(1):25. doi:10.1186/1757-4749-6-25.
   PubMedGoogle Scholar
• Grander C, Adolph TE, Wieser V, Lowe P, Wrzosek L, Gyongyosi B, Ward DV, Grabherr F, Gerner RR, Pfister A, et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut. 2018;67(5):891–901. doi:10.1136/gutjnl-2016-313432.
   PubMed Web of Science ®Google Scholar
• Png CW, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010;105(11):2420–2428. doi:10.1038/ajg.2010.281.
   PubMed Web of Science ®Google Scholar
• Reunanen J, et al. Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer. Appl Environ Microbiol. 2015;81(11):27–62. doi:10.1128/AEM.04050-14.
   Web of Science ®Google Scholar
• Belzer C, De Vos WM. Microbes inside–from diversity to function: the case of Akkermansia. ISME J. 2012;6(8):1449–1458. doi:10.1038/ismej.2012.6.
   PubMed Web of Science ®Google Scholar
• Earley H, Lennon G, Balfe A, Kilcoyne M, Clyne M, Joshi L, Carrington S, Martin ST, Coffey JC, Winter DC, et al. A Preliminary Study Examining the Binding Capacity of Akkermansia muciniphila and Desulfovibrio spp., to Colonic Mucin in Health and Ulcerative Colitis. PLoS One. 2015;10(10):e0135280. doi:10.1371/journal.pone.0135280.
   PubMed Web of Science ®Google Scholar
• Li J, Lin S, Vanhoutte PM, Woo CW, Xu A. Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice. Circulation. 2016;133(24):2434–2446. doi:10.1161/CIRCULATIONAHA.115.019645.
   PubMed Web of Science ®Google Scholar
• Yano JM, Yu K, Donaldson G, Shastri G, Ann P, Ma L, Nagler C, Ismagilov R, Mazmanian S, Hsiao E, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264–276. doi:10.1016/j.cell.2015.02.047.
   PubMed Web of Science ®Google Scholar
• Tran SM, Mohajeri MH. The Role of Gut Bacterial Metabolites in Brain Development, Aging and Disease. Nutrients. 2021;13(3):732. doi:10.3390/nu13030732.
   PubMed Web of Science ®Google Scholar
• Bojovic K, et al. Gut Microbiota Dysbiosis Associated With Altered Production of Short Chain Fatty Acids in Children With Neurodevelopmental Disorders. Front Cell Infect Microbiol. 2020;10:223. doi:10.3389/fcimb.2020.00223.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee S, Lukiw WJ. Alzheimer’s disease and the microbiome. Front Cell Neurosci. 2013;7:153. doi:10.3389/fncel.2013.00153.
   PubMed Web of Science ®Google Scholar
• Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018;1693(7):128–133. doi:10.1016/j.brainres.2018.03.015.
   PubMedGoogle Scholar
• Frohlich EE, et al. Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication. Brain Behav Immun. 2016;56:140–155. doi:10.1016/j.bbi.2016.02.020.
   PubMed Web of Science ®Google Scholar
• Borre YE, et al. The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv Exp Med Biol. 2014;817:373–403.
   PubMed Web of Science ®Google Scholar
• Reichmann F, Wegerer V, Jain P, Mayerhofer R, Hassan AM, Fröhlich EE, Bock E, Pritz E, Herzog H, Holzer P, et al. Environmental enrichment induces behavioural disturbances in neuropeptide Y knockout mice. Sci Rep. 2016;6(1):28182. doi:10.1038/srep28182.
   PubMedGoogle Scholar
• Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG, Cryan JF. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry. 2013;18(6):666–673. doi:10.1038/mp.2012.77.
   PubMed Web of Science ®Google Scholar
• Diaz Heijtz R. Fetal, neonatal, and infant microbiome: perturbations and subsequent effects on brain development and behavior. Semin Fetal Neonatal Med. 2016;21(6):410–417. doi:10.1016/j.siny.2016.04.012.
   PubMed Web of Science ®Google Scholar
• Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011;23(3):255–264 e119. doi:10.1111/j.1365-2982.2010.01620.x.
   PubMed Web of Science ®Google Scholar
• Crumeyrolle-Arias M, Jaglin M, Bruneau A, Vancassel S, Cardona A, Daugé V, Naudon L, Rabot S. Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology. 2014;42:207–217. doi:10.1016/j.psyneuen.2014.01.014.
   PubMed Web of Science ®Google Scholar
• Nishino R, et al. Commensal microbiota modulate murine behaviors in a strictly contamination-free environment confirmed by culture-based methods. Neurogastroenterol Motil. 2013;25(6):521–528. doi:10.1111/nmo.12110.
   PubMed Web of Science ®Google Scholar
• Uuskula A, Kohl PK. Genital mycoplasmas, including Mycoplasma genitalium, as sexually transmitted agents. Int J STD AIDS. 2002;13(2):79–85. doi:10.1258/0956462021924695.
   PubMed Web of Science ®Google Scholar
• De Francesco MA, Negrini R, Pinsi G, Peroni L, Manca N. Detection of Ureaplasma biovars and polymerase chain reaction-based subtyping of Ureaplasma parvum in women with or without symptoms of genital infections. Eur J Clin Microbiol Infect Dis. 2009;28(6):641–646. doi:10.1007/s10096-008-0687-z.
   PubMed Web of Science ®Google Scholar
• Horner P, Thomas B, Gilroy CB, Egger M, Taylor-Robinson D. Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis. Clin Infect Dis. 2001;32(7):995–1003. doi:10.1086/319594.
   PubMed Web of Science ®Google Scholar
• Kafetzis DA, Skevaki CL, Skouteri V, Gavrili S, Peppa K, Kostalos C, Petrochilou V, Michalas S. Maternal genital colonization with Ureaplasma urealyticum promotes preterm delivery: association of the respiratory colonization of premature infants with chronic lung disease and increased mortality. Clin Infect Dis. 2004;39(8):1113–1122. doi:10.1086/424505.
   PubMed Web of Science ®Google Scholar
• McGowin CL, Anderson-Smits C, Manchester M. Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS Pathog. 2011;7(5):e1001324. doi:10.1371/journal.ppat.1001324.
   PubMed Web of Science ®Google Scholar
• Reigstad CS, Salmonson CE, Iii JFR, Szurszewski JH, Linden DR, Sonnenburg JL, Farrugia G, Kashyap PC. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J. 2015;29(4):1395–1403. doi:10.1096/fj.14-259598.
   PubMed Web of Science ®Google Scholar
• Forsythe P, Bienenstock J. Immunomodulation by commensal and probiotic bacteria. Immunol Invest. 2010;39(4–5):429–448. doi:10.3109/08820131003667978.
   PubMed Web of Science ®Google Scholar
• Stilling RM, Dinan TG, Cryan JF. Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis. Genes Brain Behav. 2014;13(1):69–86. doi:10.1111/gbb.12109.
   PubMed Web of Science ®Google Scholar
• Macfabe DF. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis. 2012;23.
   PubMedGoogle Scholar
• Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, Deng Y, Blennerhassett PA, Fahnestock M, Moine D, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011;23(12):1132–1139. doi:10.1111/j.1365-2982.2011.01796.x.
   PubMed Web of Science ®Google Scholar
• Nohr MK, Egerod KL, Christiansen SH, Gille A, Offermanns S, Schwartz TW, Møller M. Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia. Neuroscience. 2015;290:126–137. doi:10.1016/j.neuroscience.2015.01.040.
   PubMed Web of Science ®Google Scholar
• Svensson E, Horváth-Puhó E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, Sørensen HT. Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol. 2015;78(4):522–529. doi:10.1002/ana.24448.
   PubMed Web of Science ®Google Scholar
• Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Björklund T, Wang Z-Y, Roybon L, Melki R, Li J-Y, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128(6):805–820. doi:10.1007/s00401-014-1343-6.
   PubMed Web of Science ®Google Scholar